| Mr Syed H Akhtar, RPH | |
|
9501 Farrell Rd, Fort Belvoir, VA 22060-5901 | |
| (571) 231-3253 | |
| Not Available |
| Full Name | Mr Syed H Akhtar |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 9501 Farrell Rd, Fort Belvoir, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073886917 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 010949 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Syed H Akhtar, RPH 12506 Browns Ferry Rd, Herndon, VA 20170-5708 Ph: (703) 919-9449 | Mr Syed H Akhtar, RPH 9501 Farrell Rd, Fort Belvoir, VA 22060-5901 Ph: (571) 231-3253 |
News Archive
PAREXEL International Corporation, the world's leading innovator of biopharmaceutical services, today announced an alliance with CHA Medical Group to enhance early phase clinical development in Korea.
Scientists have begun the first human clinical trial of EDP-788, an investigational oral antibiotic intended to treat methicillin-resistant Staphylococcus aureus (MRSA) infections.
HIV transmission in China is increasing faster among men who have sex with men (MSM) than in any other population, a trend that "cannot continue," a group of researchers working in China write in a Nature commentary, adding, "Policymakers, public health researchers, clinicians, educators, community leaders and other stakeholders in China must come together to educate everyone, and gay men in particular, about HIV prevention and treatment - before any more people become infected as a result of ignorance and fear."
Serono has announced that it has completed enrollment in its second multi-center, phase III trial of Serostim (somatropin [rDNA origin] for injection) in the treatment of HIV-Associated Adipose Redistribution Syndrome (HARS).
Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER® Sirolimus-eluting Coronary Stent and Medtronic's Endeavor® Stent highlighting significant and sustained clinical differences. These important findings were presented at the American College of Cardiology annual meeting, (ACC 2010) in Atlanta and published on-line in the prestigious journal The Lancet.
› Verified 6 days ago
Dr. Daraza Long, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3260 | |
Mr. Sanh Dan Trieu, BS ,RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9501 Farrell Rd, Fort Belvoir, VA 22060 Phone: 571-231-3273 | |
Dr. Koo Yeon Yoo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3224 | |
Ebony Monique Matthews, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3273 | |
Dr. Alexandra Masterson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9501 Farrell Rd, Department Of Pharmacy, Fort Belvoir, VA 22060 Phone: 703-805-0470 Fax: 703-805-0696 | |
Dr. Tiffany Limerick, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9501 Farrell Rd, Fort Belvoir, VA 22060 Phone: 571-231-3252 |